Elevance Medicare Advantage Sanctions: What Happens to Your Book When a Carrier Gets Flagged

The Elevance Medicare Advantage sanctions saga just got a new deadline, and it lands uncomfortably close to AEP. On May 30, CMS delayed its final decision on whether to suspend new enrollment in Elevance's Medicare Advantage plans until July or August 1, 2026. 

Elevance has avoided the hammer twice now. Whether it avoids it a third time matters to every agent with Anthem or Elevance plans in their carrier mix.

Here is what happened, where it stands, and how to protect your book either way.

What CMS Is Threatening and Why

CMS first notified Elevance in late February that it intended to impose intermediate sanctions, including
suspending enrollment of new Medicare beneficiaries into the company's Medicare Advantage Prescription Drug plans.

The underlying issue is risk adjustment data. According to CMS, Elevance failed to correct unsupported
diagnosis codes through the required electronic systems going back to November 2018. Instead, the
company repeatedly submitted data on encrypted USB drives, a method CMS explicitly rejected, and
continued the practice as recently as October 2025. CMS says this violated multiple requirements, including the obligation to report and return overpayments within 60 days and to certify the accuracy of data submissions.

Elevance says the issue relates to claims before April 2023 and that it has followed CMS requirements since revising its practices that year.

Where Things Stand Now

The sanctions were originally set to take effect March 31. CMS pushed that to May 30 after Elevance
requested more time, and exempted some plans, including employer group retiree plans and 11 specific contracts.

Then on May 30, CMS delayed again. The agency said it will not impose sanctions at this time because
Elevance resubmitted the disputed data and refunded estimated overpayments. But the threat is not gone. Elevance has additional steps to complete by June 30 and remaining items to close out by July 31. CMS will make its final call around July or August 1.

So this is not resolved. It is a carrier on probation with a summer deadline.

What Sanctions Would Actually Mean for Agents

If CMS imposes the sanctions, Elevance MA plans would be blocked from enrolling new members. Current members keep their coverage and benefits. The suspension affects new business only.

For agents, that breaks down like this:

• Your existing Elevance clients are fine. Their plans, benefits, and coverage continue unchanged. No
  client panic is warranted.
• You could not write new Elevance MA business while sanctions are active. That includes AEP.
  CMS has said sanctions would remain in effect until it is satisfied the deficiencies are corrected, with no automatic end date.
• The timing is the real problem. A sanction landing in July or August runs straight into AEP prep. If
  Elevance plans are a meaningful share of your recommendations, you would be rebuilding your carrier strategy weeks before the busiest season of the year.

Elevance already trimmed its MA footprint this year, dropping about 14% of its MA membership for 2026 and enrolling 1.9 million seniors. A sanction on top of that contraction would also carry reputational weight with clients who follow the news.

The Bigger Pattern: Carrier Risk Is Now Part of Your Job

Step back and look at the last 90 days. Clear Spring Health shut down its MA plans entirely, with members losing coverage May 31. Providence Health Plan announced it is winding down most of its insurance business, affecting 440,000 members. Group 1001 was fined by CMS for claims processing violations. Massachusetts just sued UnitedHealthcare over alleged Medicaid risk score manipulation. And Elevance is one CMS decision away from an enrollment freeze.

The throughline: regulators are auditing harder, carriers are under financial strain, and plan stability is no longer something agents can take for granted. A plan that looks fine in your portfolio today can be frozen, fined, or gone by next quarter.

That makes carrier risk assessment part of your job now. Star ratings, financial stability, and regulatory
standing belong in your carrier selection criteria right alongside benefits and premiums.

How to Prepare, Whatever CMS Decides

You do not need to drop Elevance. You need a plan for either outcome.

1. Know your exposure. Pull the numbers on how much of your MA book and your typical AEP production runs through Elevance plans. You cannot manage a risk you have not measured.
2. Build your contingency carrier mix now. Identify which competing plans in your counties cover similar networks and benefits. If sanctions land in July, you want that comparison work already done, not started in September.
3. Watch the July 1 window. CMS will signal its decision around then. Mark it.
4. Do not spook your clients. Existing members are unaffected. If clients ask about the headlines, the
   honest answer is that their coverage is secure and you are monitoring it.
5. Run comparisons before you need them. The agents who handled the Clear Spring exit well were the ones who had alternatives ready before clients called. Same playbook applies here.

The Bottom Line

The Elevance Medicare Advantage sanctions decision now sits at July or August 1, 2026. Existing members are safe either way, but a sanction would freeze new Elevance MA enrollment heading into AEP. Between this, the Clear Spring exit, and the Providence winddown, carrier stability has become a working variable in every agent's planning. The agents who measure their exposure and prep alternatives now will be fine no matter what CMS decides. If you want enrollment and documentation tools built around current CMS requirements, Quotit’s platform helps you stay compliant and audit-ready while you work. 

If you want a faster way to run MA plan comparisons across your counties and have a contingency mix
ready before AEP, Quotit gives you the tools to do it in a fraction of the time.

Disclaimer: This post is for educational purposes only and reflects information available at the time of publication.